Ani Pharmaceuticals reported $-3562000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aerie Pharmaceuticals AERI:US $ 51.74M 84.11M
Aurora Cannabis Inc ACB:CN -64277000 23.48M
Canopy Growth Corp WEED:CN C$ -149961000 65.4M
Depomed DEPO:US $ 5.93M 17.93M
Hikma Pharmaceutical HIK:LN 255M 88M
Nektar Therapeutics NKTR:US $ -112.91M 0.69M
Sun Pharmaceuticals SUNP:IN IR 20632.4M 1126.8M
Teva Pharmaceutical TEVA:IT 78M 545M